The downregulation of c-kit, a marker protein for ICCs, directly reflects the compromised quantity and function of ICC, while inhibition of the 5-HT signaling pathways disrupts normal intestinal motility regulation mechanisms at multiple levels (Foong et al., 2020). Here, KIT is linked to intrahepatic cholangiocarcinoma.